Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated delayed rectifier potassium channels are essential transmembrane proteins that mediate the outward potassium current (I_K) in response to membrane depolarization in neurons (StatPearls, 2023). These channels are characterized by their delayed activation kinetics, which allows the initial sodium-driven depolarization of the action potential to occur before initiating the repolarization phase (NCBI, 2022). By facilitating the efflux of potassium ions, they restore the resting membrane potential and regulate the refractory period and firing frequency of neurons (UniProt, 2024). In the central and peripheral nervous systems, these channels—primarily from the Kv1 (Shaker), Kv2 (Shab), and Kv3 (Shaw) families—play a pivotal role in maintaining electrical stability and fine-tuning synaptic transmission (IUPHAR/BPS, 2023). Mutations in the genes encoding these channels, such as KCNB1 or KCNA1, are associated with channelopathies including epilepsy, episodic ataxia, and certain types of neuropathic pain (PubMed, 2021). Therapeutically, potassium channel blockers like 4-aminopyridine are utilized to enhance axonal conduction in conditions like multiple sclerosis, while research continues into selective activators for treating hyperexcitability disorders (PubChem, 2024). These channels also serve as targets for various neurotoxins, which have been instrumental in characterizing their structure and function (Guide to Pharmacology, 2023).
Blockade of the potassium-selective pore to delay repolarization, thereby prolonging the action potential and increasing calcium influx at the presynaptic terminal to enhance neurotransmitter release.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated delayed rectifier potassium channel (Kv channel).